MedTrace Logo

Evaluation of the Novel Silq ClearTract Catheter in Patients With Chronic Urinary Retention

NCT05931887 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 115

Last updated 2026-04-24

No results posted yet for this study

Summary

To assess the ability of the Silq ClearTract™ 100% Silicone 2-Way Foley Catheter to reduce catheter associated complications in subjects that require a long-term indwelling Foley catheter when compared to other commercially available Foley catheters.

Conditions

  • Catheter Infection
  • Catheter Blockage
  • Catheter Related Complication
  • Catheter Calcification

Interventions

DEVICE

SILQ ClearTract 100% Silicone 2-Way Foley Catheter

A foley catheter is assigned and used according to regular standard of care

Sponsors & Collaborators

  • Silq Technologies Corporation

    lead INDUSTRY

Principal Investigators

  • Evgeniy Kreydin, M.D. · Rancho Los Amigos National Rehabilitation Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-26
Primary Completion
2025-12-31
Completion
2026-04-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05931887 on ClinicalTrials.gov